Who Buys Allopurinol from India — 378 Importers Behind a $492.9M Market
India's allopurinol import market is served by 378 active buyers who collectively imported $492.9M across 4,362 shipments. UNICHEM PHARMACEUTICALS (USA) INC (UNITED STATES) leads with a 12.8% market share, followed by UNICHEM PHARMACEUTICALS (USA) INC. and LEK D.D. The top 5 buyers together control 31.1% of total import value, reflecting a moderately competitive buyer landscape.
Top Allopurinol Importers — Ranked by Import Value
UNICHEM PHARMACEUTICALS (USA) INC (UNITED STATES) is the leading allopurinol importer from India, holding a 12.8% share of the $492.9M market across 4,362 shipments from 378 buyers. The top 5 buyers — UNICHEM PHARMACEUTICALS (USA) INC (UNITED STATES), UNICHEM PHARMACEUTICALS (USA) INC. (UNITED STATES), LEK D.D (SLOVENIA), IPCA LABORATORIES UK LIMITED (UNITED KINGDOM), UNICHEM PHARMACEUTICALS USA INC (UNITED STATES) — collectively control 31.1% of total import value.
Top Allopurinol Buyers & Importers
Ranked by import value · 378 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | UNICHEM PHARMACEUTICALS (USA) INCUNITED STATES ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $63.1M | 5 | 12.8% |
| 2 | UNICHEM PHARMACEUTICALS (USA) INC.UNITED STATES ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $52.7M | 5 | 10.7% |
| 3 | LEK D.DSLOVENIA MATERIAL NO. - 42031699, ALLOPURINOL TAB300MG IN91 EU 01,ALLOPURINOL TAB 300MG IN91 SH EU 02 MATERIAL NO. - 42034619ALLOPURINOL TAB 300MG IN91 EU 01 MATERIA | $25.3M | 5 | 5.1% |
| 4 | IPCA LABORATORIES UK LIMITEDUNITED KINGDOM ALLOPURINOL 300MG TABLETSALLOPURINOL 100MG TABLETSALLOPURINOL 300 MG TABLETS | $7.1M | 5 | 1.5% |
| 5 | UNICHEM PHARMACEUTICALS USA INCUNITED STATES ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $5.3M | 5 | 1.1% |
| 6 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $3.4M | 5 | 0.7% |
| 7 | MARCAN PHARMACEUTICALS INC.CANADA HARMLESS MEDICINES : MAR-ALLOPURINOL 300MG UNIT RHARMLESS MEDICINES:MAR-ALLOPURINOL 300MGHARMLESS MEDICINES : MAR-ALLOPURINOL 300MG UNIT RA | $2.8M | 5 | 0.6% |
| 8 | UNICHEM PHARMACEUTICALS (USA), INCUNITED STATES ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $1.9M | 5 | 0.4% |
| 9 | SANDOZ PTY LIMITEDAUSTRALIA ALLOPURINOL SDZ 300MG 60TAB BO V2 AU MATALLOPURINOL SDZ 100MG 200TAB BO V2 AU MAALLOPURINOL APOTEX 300MG TABLETS (ALLOPU | $1.2M | 5 | 0.3% |
| 10 | UNICHEM PHARMACEUTICALS (USA) INC..UNITED STATES ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $924.9K | 5 | 0.2% |
| 11 | MYLAN ITALIA SRLITALY | $898.0K | 5 | 0.2% |
| 12 | HEUMANN PHARMA GMBH CO.GENERICA KG.GERMANY ALLOPURINOL TABLETS 300MG ,PACK OF 10X1ALLOPURINOL TABLETS 100MG ,PACK OF 10X1ALLOPURINOL TABLETS 300MG EACH ALLOP | $757.6K | 5 | 0.2% |
| 13 | MARCAN PHARMACEUTICALS INCCANADA HARMLESS MEDICINES : MAR-ALLOPURINOL 300MG UNIT RHARMLESS MEDICINES:MAR-ALLOPURINOL 300MGHARMLESS MEDICINES : MAR-ALLOPURINOL 300MG UNIT RA | $748.9K | 5 | 0.2% |
| 14 | APOTEX PTY LTDAUSTRALIA ALLOPURINOL SDZ 300MG 60TAB BO V2 AU MATALLOPURINOL SDZ 100MG 200TAB BO V2 AU MAALLOPURINOL APOTEX 300MG TABLETS (ALLOPU | $739.8K | 5 | 0.2% |
| 15 | ORION CORPORATIONFINLAND ALLOPURINOL 300MG TABLETSALLOPURINOL 100MG TABLETS76410X10X10'SPACK =7641000 TABLETSALLOPURINOL 100MG TABLETS(92960X10X10'S | $733.1K | 5 | 0.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Allopurinol — and from which countries?
Flow of Allopurinol exports from India: each country's share and the named importers behind the numbers
Allopurinol — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $256.9M through 475 shipments. This represents a market share of 52.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• UNICHEM PHARMACEUTICALS (USA) INC - $63.1M (24.6% of country's total business)
• UNICHEM PHARMACEUTICALS (USA) INC. - $52.7M (20.5% of country's total business)
• UNICHEM PHARMACEUTICALS USA INC - $5.3M (2.0% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES - $3.4M (1.3% of country's total business)
• UNICHEM PHARMACEUTICALS (USA), INC - $1.9M (0.7% of country's total business)
• Rest of United States's importers - $130.5M (50.8% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $540.8K, indicating premium pricing strategy compared to the market average of $113.0K.
United States is a key market for Allopurinol imports, representing 52.1% of total trade value.
2New Zealand
New Zealand emerges as the second largest importing country, achieving a total trade value of $132.6M through 0 shipments. This represents a market share of 26.9% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: New Zealand demonstrates strong market positioning with an average shipment value of $132.6M, indicating premium pricing strategy compared to the market average of $113.0K.
New Zealand is a key market for Allopurinol imports, representing 26.9% of total trade value.
3Slovenia
Slovenia emerges as the third largest importing country, achieving a total trade value of $26.9M through 34 shipments. This represents a market share of 5.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Slovenia has a diverse importer base, with their top importers including:
• LEK D.D - $25.3M (94.1% of country's total business)
Key Insight: Slovenia demonstrates strong market positioning with an average shipment value of $791.1K, indicating premium pricing strategy compared to the market average of $113.0K.
Slovenia is a key market for Allopurinol imports, representing 5.5% of total trade value.
4Australia
Australia emerges as the fourth largest importing country, achieving a total trade value of $19.7M through 22 shipments. This represents a market share of 4.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• SANDOZ PTY LIMITED - $1.2M (6.3% of country's total business)
• APOTEX PTY LTD - $739.8K (3.8% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $893.7K, indicating premium pricing strategy compared to the market average of $113.0K.
Australia is a key market for Allopurinol imports, representing 4.0% of total trade value.
5Germany
Germany emerges as the fifth largest importing country, achieving a total trade value of $15.6M through 15 shipments. This represents a market share of 3.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• HEUMANN PHARMA GMBH CO.GENERICA KG. - $757.6K (4.9% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $1.0M, indicating premium pricing strategy compared to the market average of $113.0K.
Germany is a key market for Allopurinol imports, representing 3.2% of total trade value.
Buyer Segment Analysis
TransData Nexus Allopurinol buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Allopurinol imported from India encompasses several key segments:
1. Pharmaceutical Companies: Entities like UNICHEM PHARMACEUTICALS (USA) INC and LEK D.D (Slovenia) are prominent buyers. These companies procure Allopurinol in bulk to manufacture and distribute under their brand names. Their purchasing patterns are characterized by large, consistent orders to maintain steady supply chains and meet market demand.
2. Distributors: Companies such as EVERSANA LIFE SCIENCE SERVICES (United States) and MARCAN PHARMACEUTICALS INC. (Canada) fall into this category. They purchase Allopurinol to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior often involves moderate to large orders, aligning with market demand fluctuations and inventory management strategies.
3. Contract Manufacturers: Entities like IPCA LABORATORIES UK LIMITED (United Kingdom) serve as contract manufacturers, producing Allopurinol for other pharmaceutical companies or brands. Their procurement is typically in large quantities, dictated by contractual agreements and production schedules.
Each segment's purchasing behavior reflects their role in the supply chain, with pharmaceutical companies and contract manufacturers focusing on large-scale procurement for production, while distributors adjust their orders based on market demand and distribution needs.
Country-Specific Import Regulations
TransData Nexus Allopurinol buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Allopurinol from India, the import regulations are as follows:
1. United States:
2. New Zealand:
3. Slovenia:
4. Australia:
5. Germany:
Demand Drivers & Market Opportunity
TransData Nexus Allopurinol buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Allopurinol in importing countries is driven by several factors:
1. Disease Prevalence: Allopurinol is primarily used to treat gout and hyperuricemia. The prevalence of these conditions has been rising globally due to factors such as aging populations and lifestyle changes. For instance, a 2025 study indicated that gout affects approximately 4% of adults in the United States, highlighting a significant patient base requiring Allopurinol therapy.
2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding their healthcare programs and striving for UHC, increasing access to essential medicines. The inclusion of Allopurinol in national essential medicines lists, as recommended by the WHO Model List of Essential Medicines, facilitates its procurement and distribution. (who.int)
3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Allopurinol's presence on the WHO Model List of Essential Medicines underscores its importance in treating gout and related conditions. This inclusion encourages countries to prioritize its procurement through tender-based purchasing, ensuring availability in public healthcare systems. (who.int)
With 378 buyers across 102 countries, the global market for Allopurinol presents substantial opportunities. The combination of increasing disease prevalence, supportive government policies, and its status as an essential medicine positions Allopurinol as a critical component in managing gout and hyperuricemia worldwide.
Common Questions — Allopurinol Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest allopurinol buyer importing from India?
Based on import volume and value, UNICHEM PHARMACEUTICALS (USA) INC (UNITED STATES) leads with $63.1M in imports and a 12.8% market share — the highest of any single allopurinol importer. UNICHEM PHARMACEUTICALS (USA) INC. (UNITED STATES) and LEK D.D (SLOVENIA) are the next largest buyers.
QHow many companies buy allopurinol from India?
There are 378 active allopurinol buyers importing from India, with a combined market of $492.9M across 4,362 shipments to 102 countries. The top 5 buyers hold 31.1% of total import value, while the remaining 373 buyers handle the other 68.9%.
QWhich countries import the most allopurinol from India?
The top importing countries for allopurinol from India are United States (52.1%), New Zealand (26.9%), Slovenia (5.5%), Australia (4.0%), Germany (3.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of allopurinol, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for allopurinol from India?
The average import transaction value for allopurinol from India is $113.0K, with an average unit price of $5.11 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Allopurinol buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Allopurinol imported from India encompasses several key segments:
1. Pharmaceutical Companies: Entities like UNICHEM PHARMACEUTICALS (USA) INC and LEK D.D (Slovenia) are prominent buyers. These companies procure Allopurinol in bulk to manufacture and distribute under their brand names. Their purchasing patterns are characterized by large, consistent orders to maintain steady supply chains and meet market demand.
2. Distributors: Companies such as EVERSANA LIFE SCIENCE SERVICES (United States) and MARCAN PHARMACEUTICALS INC. (Canada) fall into this category. They purchase Allopurinol to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior often involves moderate to large orders, aligning with market demand fluctuations and inventory management strategies.
3. Contract Manufacturers: Entities like IPCA LABORATORIES UK LIMITED (United Kingdom) serve as contract manufacturers, producing Allopurinol for other pharmaceutical companies or brands. Their procurement is typically in large quantities, dictated by contractual agreements and production schedules.
Each segment's purchasing behavior reflects their role in the supply chain, with pharmaceutical companies and contract manufacturers focusing on large-scale procurement for production, while distributors adjust their orders based on market demand and distribution needs.
Country-Specific Import Regulations
TransData Nexus Allopurinol buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Allopurinol from India, the import regulations are as follows:
1. United States:
2. New Zealand:
3. Slovenia:
4. Australia:
5. Germany:
Demand Drivers & Market Opportunity
TransData Nexus Allopurinol buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Allopurinol in importing countries is driven by several factors:
1. Disease Prevalence: Allopurinol is primarily used to treat gout and hyperuricemia. The prevalence of these conditions has been rising globally due to factors such as aging populations and lifestyle changes. For instance, a 2025 study indicated that gout affects approximately 4% of adults in the United States, highlighting a significant patient base requiring Allopurinol therapy.
2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding their healthcare programs and striving for UHC, increasing access to essential medicines. The inclusion of Allopurinol in national essential medicines lists, as recommended by the WHO Model List of Essential Medicines, facilitates its procurement and distribution. (who.int)
3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Allopurinol's presence on the WHO Model List of Essential Medicines underscores its importance in treating gout and related conditions. This inclusion encourages countries to prioritize its procurement through tender-based purchasing, ensuring availability in public healthcare systems. (who.int)
With 378 buyers across 102 countries, the global market for Allopurinol presents substantial opportunities. The combination of increasing disease prevalence, supportive government policies, and its status as an essential medicine positions Allopurinol as a critical component in managing gout and hyperuricemia worldwide.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 378 global importers of Allopurinol identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 4,362 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 102 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,362 Verified Shipments
378 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists